In patients with type 2 diabetes GPR26 was downregulated due to chronic hyperglycemic conditions and accompanied by increased production of reactive oxygen species, pro-inflammatory monocyte activation and apoptosis [37]. Here, GPR26 is linked to type 2 diabetes mellitus.